RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.

RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
复制标题

RhoC 是 microRNA-93-5P 在上皮性卵巢癌肿瘤发生和进展中的主要靶标

DOI:
10.1186/s12943-015-0304-6
复制
发表时间:
2015-02-04
期刊:
影响因子:
37.3
通讯作者:
Zhao Y
Zhao Y
中科院分区:
医学1区
文献类型:
--
作者:
Chen X;Chen S;Xiu YL;Sun KX;Zong ZH;Zhao Y

文献摘要

参考文献

被引文献

相似文献

越来越多的证据表明,microRNA调节各种生物学过程,包括细胞分化、细胞增殖、细胞凋亡、耐药性和脂肪代谢。研究表明,miR-93在癌症中的靶组尚未完全确定。此外,miR-93在上皮性卵巢癌(EOC)中的作用仍然很大程度上未知。对正常卵巢组织、良性肿瘤、交界性肿瘤、原发性卵巢癌和转移性网膜中的MIR-93 mRNA表达进行定量。将miR-93- 5 P转染卵巢癌细胞株OVCAR 3、SKOV 3/DDP和HO 8910-PM,检测细胞表型和相关分子的表达。采用双荧光素酶报告基因分析和异种移植小鼠模型检测miR-93及其靶基因RHOC(Ras homolog gene family member C)。MIR-93 mRNA在卵巢癌和交界性肿瘤中的表达明显低于正常卵巢组织(p < 0.05),在转移性大网膜中的表达明显低于相对原发性卵巢癌(p < 0.05)。miR-93 mRNA的表达与卵巢癌的分化程度(良、差、中)、国际妇产科联盟分期(FIGO I/II期、III/IV期)呈负相关(p < 0.05),且在粘液腺癌中的表达高于其他类型(p < 0.05)。miR-93- 5 P过表达降低增殖(p < 0.05);促进G1或S期阻滞和凋亡(p <0.05);抑制迁移和侵袭(p < 0.05);并降低RhoC、P70 S6激酶、Bcl-xL、基质金属蛋白酶9(MMP 9)mRNA或蛋白表达;相反,它诱导P53和切割PARP表达(p < 0.05)。双荧光素酶报告基因检测表明,miR-93通过与RhoC的3′端非翻译区结合而直接靶向RhoC。MiR-93- 5 P转染还在异种移植小鼠模型中体内抑制肿瘤发展和RhoC表达(通过免疫组织化学测定)(p < 0.05)。这是首次证明miR-93- 5 P可以通过靶向RhoC抑制EOC肿瘤发生和进展。这些发现表明miR-93- 5 P是卵巢细胞增殖的潜在抑制剂。miR-93- 5 P介导的RhoC下调参与抑制EOC侵袭性,可能为深入了解癌症侵袭性的分子机制提供更多信息。
An increasing amount of evidence has revealed that microRNAs regulate various biological processes, including cell differentiation, cell proliferation, apoptosis, drug resistance, and fat metabolism. Studies have shown that miR-93’s targetome in cancer has not been fully defined. Moreover, the role of miR-93 in epithelial ovarian carcinoma (EOC) remains largely unknown. MIR-93 mRNA expression in normal ovarian tissue, benign tumors, borderline tumors, primary ovarian carcinomas, and metastatic omentum was quantified. The ovarian carcinoma cell lines OVCAR3, SKOV3/DDP, and HO8910-PM were transfected with miR-93-5P, after which cell phenotype and expression of relevant molecules were assayed. Dual-luciferase reporter assay and a xenograft mouse model were used to examine miR-93 and its target gene RHOC (Ras homolog gene family member C). MIR-93 mRNA expression was significantly lower in ovarian carcinomas and borderline tumors than in normal ovarian tissues (p < 0.05), and was lower in metastatic omentum than in relative primary ovarian carcinomas (p < 0.05). MIR-93 mRNA expression was also negatively associated with differentiation (well vs. poor and moderate) and International Federation of Gynecology and Obstetrics staging (FIGO stage I/II vs. stage III/IV) in ovarian carcinoma (p < 0.05), besides, miR-93 was higher expressed in mucinous adenocarcinoma than the other types (p < 0.05). MiR-93-5P overexpression reduced proliferation (p < 0.05); promoted G1 or S arrest and apoptosis (p < 0.05); suppressed migration and invasion (p < 0.05); and reduced RhoC, P70S6 kinase, Bcl-xL, matrix metalloproteinase 9 (MMP9) mRNA or protein expression; conversely, it induced P53 and cleaved PARP expression (p < 0.05). Dual-luciferase reporter assay indicated that miR-93 directly targeted RhoC by binding its 3′ untranslated region. MiR-93-5P transfection also suppressed tumor development and RhoC expression (determined by immunohistochemistry) in vivo in the xenograft mouse model (p < 0.05). This is the first demonstration that miR-93-5P may inhibit EOC tumorigenesis and progression by targeting RhoC. These findings indicate that miR-93-5P is a potential suppressor of ovarian cellular proliferation. The involvement of miR-93-5P–mediated RhoC downregulation in inhibiting EOC aggressiveness may provide extended insight into the molecular mechanisms underlying cancer aggressiveness.
DOI: 10.1371/journal.pone.0061622
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Sanchez-Diaz PC;Hsiao TH;Chang JC;Yue D;Tan MC;Chen HI;Tomlinson GE;Huang Y;Chen Y;Hung JY
通讯作者: Hung JY
DOI: 10.1158/1078-0432.ccr-07-1731
发表时间: 2008-05-01
影响因子: 11.5
作者:
Nam, Eun Ji;Yoon, Heejei;Kim, Sunghoon
通讯作者: Kim, Sunghoon
DOI: 10.1074/jbc.m110.136168
发表时间: 2010-07-23
影响因子: 4.8
作者:
Long, Jianyin;Wang, Yin;Danesh, Farhad R.
通讯作者: Danesh, Farhad R.
DOI: 10.1158/1541-7786.mcr-08-0512
发表时间: 2009-11
期刊: Molecular cancer research : MCR
影响因子: --
作者:
Islam M;Lin G;Brenner JC;Pan Q;Merajver SD;Hou Y;Kumar P;Teknos TN
通讯作者: Teknos TN
DOI: 10.1002/path.2806
发表时间: 2011-01
影响因子: 7.3
作者:
Farazi, Thalia A.;Spitzer, Jessica I.;Morozov, Pavel;Tuschl, Thomas
通讯作者: Tuschl, Thomas